Annual report
6545.TEDINET S100OGWT
Period2021-04-01 → 2022-03-31
Filed2022-06-27
StandardJapan GAAP
ConsolidatedYes
Data checks17 of 17 passed
Key figures · 106
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥156m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥290m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥287m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥186m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥186m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥2.8bn | at 2022-03-31 | Cons. | Assets |
| Total liabilities | ¥1.6bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.2bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.0bn | at 2021-03-31 | Cons. | Net assets |
| Cash and deposits | ¥1.1bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥845m | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥272m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥236m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥250m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥34.67 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥33.74 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥231.64 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 44.0% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 15.0% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| Employees | 329 | at 2022-03-31 | Cons. | Number of employees |
| Revenue | ¥3.5bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥3.5bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥3.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.4bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.3bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥148m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥165m | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥281m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥250m | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥216m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥104m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥279m | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥278m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥226m | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥187m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥150m | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥122m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥65m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥186m | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.7bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥2.3bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥2.5bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.9bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.7bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.3bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.2bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.0bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥853m | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥816m | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥672m | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.0bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥845m | at 2021-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥845m | at 2021-03-31 | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥930m | at 2020-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥430m | at 2019-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥405m | at 2018-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥362m | 2020-04-01 → 2021-03-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥395m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥154m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥321m | 2017-04-01 → 2018-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥104m | 2020-04-01 → 2021-03-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥170m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥168m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥248m | 2017-04-01 → 2018-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥343m | 2020-04-01 → 2021-03-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥275m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥39m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥109m | 2017-04-01 → 2018-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥34.85 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.08 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.96 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.12 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.04 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥33.91 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.29 | 2020-04-01 → 2021-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥22.21 | 2019-04-01 → 2020-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥11.64 | 2018-04-01 → 2019-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥33.15 | 2017-04-01 → 2018-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥232.38 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥190.07 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥160.09 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥150.79 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥133.95 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 46.0% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.4% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.7% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.8% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.8% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 16.5% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.1% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.7% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.7% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 32.1% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 5,427,771 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,427,771 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,427,771 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,413,371 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,017,600 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 296 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 319 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 301 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 292 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 267 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥4m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥560m |
| Health Care Solution Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥121m |
| Health Care Solution Businessreportable segment | employees | at 2022-03-31 | 201 pure |
| Health Care Solution Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥2.9bn |
| Health Care Solution Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥2.9bn |
| Health Care Solution Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥338m |
| Home Care Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥7m |
| Home Care Businessreportable segment | employees | at 2022-03-31 | 91 pure |
| Home Care Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| Home Care Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| Home Care Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥378m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥128m |
| —segment total | employees | at 2022-03-31 | 292 pure |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥4.2bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥4.2bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥716m |
| Health Care Solution Businessreportable segment | employees | at 2022-03-31 | 168 pure |
| Home Care Businessreportable segment | employees | at 2022-03-31 | 91 pure |
| —segment total | employees | at 2022-03-31 | 259 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,037
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenues from external customers information for each region (text) | CurrentYearDuration | Text · Plus | |
| Property plant and equipment information for each region (text) | CurrentYearDuration | Text · Plus | |
| Information for each of main customers (text) | CurrentYearDuration | Text · Plus | |
| Description of factors which led to recognition of gain on bargain purchase (text) | CurrentYearDuration | Text · Plus | |
| Notes related parties consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes per share information consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes significant events after reporting period consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed consolidated detailed schedule of corporate bonds (text) | CurrentYearDuration | Text · Plus | |
| Annexed consolidated detailed schedule of borrowings (text) | CurrentYearDuration | Text · Plus | |
| Annexed consolidated detailed schedule of asset retirement obligations (text) | CurrentYearDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYearDuration | Text · Plus | |
| Balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Statement of income (text) | CurrentYearDuration | Text · Plus | |
| Detailed schedule of cost of sales (text) | CurrentYearDuration | Text · Plus | |
| Statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies financial statements (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in presentation financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding assets and liabilities incurred from transactions with affiliated entities (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Notes regarding amounts of reduction entry of property plant and equipment (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Notes regarding total amount of operating transactions from or to affiliated entities and total amount of non operating transactions from or to affiliated entities (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding subsidy income (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes securities financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes tax effect accounting financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes business combinations financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes revenue recognition financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes significant events after reporting period financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of property plant and equipment etc (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of provisions (text) | CurrentYearDuration | Text · Plus | |
| Components of major assets and liabilities (text) | CurrentYearDuration | Text · Plus | |
| Other information financial statements etc (text) | CurrentYearDuration | Text · Plus | |
| Overview of operational procedures for shares (text) | FilingDateInstant | Text · Plus | |
| Information about parent company etc of reporting company (text) | FilingDateInstant | Text · Plus | |
| Other reference information (text) | FilingDateInstant | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 17 of 17 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |